SCHEMBL30535443

SCHEMBL30535443

CS(=O)(=O)Nc1cc(Cl)cc(NC(=O)c2cc(C(=O)Nc3ccccc3)cs2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ HTT P42858 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ RAB9A P51151 3/20 0.47
▸ TP53 P04637 1/20 0.47
▸ MAPT P10636 4/20 0.46
▸ GAA P10253 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ NPC1 O15118 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ LMNA P02545 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351564 1.00 MEN1 (0.50) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL30535367 0.89 MEN1 (0.45) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL25351103 0.89 MEN1 (0.45) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL30543946 0.89 DHX9 (0.53) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL25368280 0.89 DHX9 (0.53) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL25368447 0.87 HPGD (0.51) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL31560992 0.87 ADORA3 (0.51) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL25351576 0.85 MEN1 (0.51) MEN1KMT2AHTTSMN1; SMN2ALDH1A1
SCHEMBL25368915 0.85 RAB9A (0.47) MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A
SCHEMBL30543940 0.85 RAB9A (0.47) MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119923385-A Inhibitors of RNA helicase DHX9 and uses thereof 埃克森特治疗公司 2025-05-02 — — CN disclosed
WO-2025080900-A1 INHIBITORS OF THE RNA HELICASE DHX9 FOR USE IN THE TREATMENT OF DNA DAMAGE REPAIR DEFICIENT, HOMOLOGOUS RECOMBINATION DEFICIENT, AND CANCERS HAVING A BRCA LOSS OF FUNCTION MUTATION ACCENT THERAPEUTICS, INC. (US) 2025-04-17 — — WO disclosed
EP-4479138-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 — — EP disclosed
WO-2023154519-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-17 — — WO disclosed
Send feedback